Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation.

Christian D Sadik, Andrew D Luster
Author Information
  1. Christian D Sadik: Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Abstract

Chemoattractants are pivotal mediators of host defense, orchestrating the recruitment of immune cells into sites of infection and inflammation. Chemoattractants display vast chemical diversity and include bioactive lipids, proteolytic fragments of serum proteins, and chemokines (chemotactic cytokines). All chemoattractants induce chemotaxis by activating seven-transmembrane-spanning GPCRs expressed on immune cells, establishing the concept that all chemoattractants are related in function. However, although chemoattractants have overlapping functions in vitro, recent in vivo data have revealed that they function, in many cases, nonredundantly in vivo. The chemically diverse nature of chemoattractants contributes to the fine control of leukocyte trafficking in vivo, with sequential chemoattractant use guiding immune cell recruitment into inflammatory sites. Lipid mediators frequently function as initiators of leukocyte recruitment, attracting the first immune cells into tissues. These initial responding immune cells produce cytokines locally, which in turn, induce the local release of chemokines. Local chemokine production then markedly amplifies subsequent waves of leukocyte recruitment. These new discoveries establish a paradigm for leukocyte recruitment in inflammation--described as lipid-cytokine-chemokine cascades--as a driving force in the effector phase of immune responses.

References

  1. J Immunol. 2010 Apr 15;184(8):4568-74 [PMID: 20237293]
  2. J Immunol. 1996 Nov 15;157(10):4664-71 [PMID: 8906847]
  3. FASEB J. 2002 Feb;16(2):228-30 [PMID: 11744622]
  4. Proc Natl Acad Sci U S A. 1984 Feb;81(3):689-93 [PMID: 6322165]
  5. Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1761-7 [PMID: 12947016]
  6. J Immunol. 2011 Oct 15;187(8):4319-30 [PMID: 21918195]
  7. J Immunol. 2002 Jan 1;168(1):443-9 [PMID: 11751991]
  8. Am J Physiol Lung Cell Mol Physiol. 2004 Mar;286(3):L465-72 [PMID: 14617513]
  9. Br J Pharmacol. 2003 May;139(2):388-98 [PMID: 12770944]
  10. Shock. 2005 Apr;23(4):344-52 [PMID: 15803058]
  11. Proc Natl Acad Sci U S A. 1986 Mar;83(5):1349-53 [PMID: 3006048]
  12. Autoimmun Rev. 2011 Oct;10(12):793-800 [PMID: 21740985]
  13. J Immunol. 2001 Feb 1;166(3):2055-62 [PMID: 11160256]
  14. Pharmacology. 2009;84(3):171-82 [PMID: 19713720]
  15. Science. 2010 Jan 29;327(5965):580-3 [PMID: 20110505]
  16. J Allergy Clin Immunol. 2002 Apr;109(4):615-20 [PMID: 11941309]
  17. Trends Mol Med. 2006 Apr;12(4):148-58 [PMID: 16545607]
  18. Science. 2011 Jan 14;331(6014):217-9 [PMID: 21233389]
  19. Nat Immunol. 2006 Mar;7(3):311-7 [PMID: 16462739]
  20. Am Rev Respir Dis. 1990 Jul;142(1):126-32 [PMID: 2368958]
  21. Nat Rev Immunol. 2010 Dec;10(12):838-48 [PMID: 21060320]
  22. J Lipid Res. 2009 Apr;50 Suppl:S231-6 [PMID: 19109234]
  23. Annu Rev Immunol. 2008;26:205-32 [PMID: 18304002]
  24. Am Rev Respir Dis. 1989 Feb;139(2):450-7 [PMID: 2643903]
  25. J Exp Med. 2002 Jul 1;196(1):77-85 [PMID: 12093872]
  26. J Biol Chem. 1995 Aug 11;270(32):18910-6 [PMID: 7642548]
  27. N Engl J Med. 2007 Nov 1;357(18):1841-54 [PMID: 17978293]
  28. J Immunol. 2006 Sep 1;177(5):3439-47 [PMID: 16920986]
  29. Immunity. 2010 Aug 27;33(2):148-9 [PMID: 20732637]
  30. Eur Respir J. 2004 Jun;23(6):876-84 [PMID: 15219001]
  31. J Asthma. 1998;35(5):445-8 [PMID: 9734352]
  32. Blood. 2007 Jan 15;109(2):626-31 [PMID: 16985179]
  33. J Immunol. 2007 Feb 1;178(3):1882-95 [PMID: 17237439]
  34. J Cell Biol. 1999 Nov 1;147(3):577-88 [PMID: 10545501]
  35. J Clin Invest. 1980 Nov;66(5):1166-70 [PMID: 6253525]
  36. Nat Immunol. 2003 Oct;4(10):982-90 [PMID: 12949531]
  37. Science. 1998 Dec 18;282(5397):2261-3 [PMID: 9856950]
  38. Prostaglandins Other Lipid Mediat. 2009 Sep;89(3-4):98-104 [PMID: 19450703]
  39. Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1783-8 [PMID: 15271789]
  40. ScientificWorldJournal. 2007 Sep 01;7:1307-28 [PMID: 17767352]
  41. Annu Rev Pharmacol Toxicol. 2008;48:171-97 [PMID: 17883327]
  42. Eur Cytokine Netw. 2003 Oct-Dec;14(4):219-28 [PMID: 14715413]
  43. J Exp Med. 2005 Jun 20;201(12):1961-71 [PMID: 15955837]
  44. Cell. 1996 Nov 29;87(5):811-22 [PMID: 8945509]
  45. Arterioscler Thromb Vasc Biol. 2011 May;31(5):986-1000 [PMID: 21508345]
  46. Science. 1998 Dec 18;282(5397):2258-61 [PMID: 9856949]
  47. J Clin Invest. 2006 Mar;116(3):783-96 [PMID: 16511606]
  48. J Immunol. 2010 Nov 1;185(9):5503-11 [PMID: 20876351]
  49. J Cell Biol. 1997 Dec 1;139(5):1349-60 [PMID: 9382879]
  50. J Immunol. 1990 May 1;144(9):3347-53 [PMID: 2109776]
  51. J Pharmacol Exp Ther. 1995 Apr;273(1):176-84 [PMID: 7714764]
  52. J Immunol. 2005 Oct 1;175(7):4217-25 [PMID: 16177061]
  53. J Clin Invest. 2002 May;109(10):1373-80 [PMID: 12021253]
  54. J Immunol. 2001 Aug 1;167(3):1601-8 [PMID: 11466382]
  55. Pharmacol Ther. 2004 Aug;103(2):147-66 [PMID: 15369681]
  56. Nat Rev Immunol. 2009 Dec;9(12):858-70 [PMID: 19935805]
  57. Science. 1999 Nov 26;286(5445):1732-5 [PMID: 10576739]
  58. Clin Exp Immunol. 2010 Jul 1;161(1):34-40 [PMID: 20491797]
  59. J Allergy Clin Immunol. 2001 Feb;107(2):272-8 [PMID: 11174193]
  60. J Immunol. 2010 Sep 1;185(5):3049-56 [PMID: 20656922]
  61. J Immunol. 2005 Nov 15;175(10):6531-6 [PMID: 16272307]
  62. Am J Respir Crit Care Med. 1995 Sep;152(3):897-905 [PMID: 7663802]
  63. J Leukoc Biol. 2007 Jun;81(6):1434-44 [PMID: 17339609]
  64. Nat Immunol. 2003 Oct;4(10):974-81 [PMID: 12949532]
  65. Nat Immunol. 2008 Jul;9(7):743-52 [PMID: 18536720]
  66. Prostaglandins Leukot Essent Fatty Acids. 2003 Aug-Sep;69(2-3):163-7 [PMID: 12895599]
  67. J Immunol. 1984 Oct;133(4):2138-44 [PMID: 6206153]
  68. Immunity. 2009 Sep 18;31(3):425-37 [PMID: 19766085]
  69. Inflamm Allergy Drug Targets. 2009 Jul;8(3):182-90 [PMID: 19601878]
  70. J Exp Med. 2005 Mar 21;201(6):981-91 [PMID: 15781587]
  71. Nat Immunol. 2003 Oct;4(10):965-73 [PMID: 12949533]
  72. Nat Neurosci. 2011 Jul 31;14(9):1142-9 [PMID: 21804537]
  73. Arthritis Rheum. 2008 May;58(5):1354-65 [PMID: 18438856]
  74. J Immunol. 2007 Nov 1;179(9):5760-7 [PMID: 17947648]
  75. Immunity. 2010 Aug 27;33(2):266-78 [PMID: 20727790]
  76. Nature. 1990 Jan 18;343(6255):282-4 [PMID: 2300173]
  77. J Lipid Res. 2009 Apr;50 Suppl:S40-5 [PMID: 18987389]
  78. Am J Respir Crit Care Med. 2002 Nov 15;166(10):1345-9 [PMID: 12406853]
  79. J Exp Med. 2000 Aug 7;192(3):433-8 [PMID: 10934231]
  80. J Exp Med. 1998 Sep 21;188(6):1063-74 [PMID: 9743525]
  81. Science. 2010 Oct 15;330(6002):362-6 [PMID: 20947763]
  82. J Allergy Clin Immunol. 2003 Nov;112(5):930-4 [PMID: 14610482]
  83. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2325-30 [PMID: 17277081]
  84. J Exp Med. 2003 Aug 18;198(4):533-43 [PMID: 12925672]
  85. Nat Rev Immunol. 2011 Jul 25;11(8):519-31 [PMID: 21785456]
  86. N Engl J Med. 1986 Sep 25;315(13):800-4 [PMID: 3462506]
  87. Nat Rev Immunol. 2011 Jan;11(1):9-20 [PMID: 21151034]
  88. Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L170-8 [PMID: 16126787]
  89. Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):369-75 [PMID: 14656734]
  90. Nat Rev Immunol. 2004 Sep;4(9):711-24 [PMID: 15343370]
  91. Clin Exp Allergy. 2005 Sep;35(9):1125-34 [PMID: 16164437]
  92. J Exp Med. 2006 Apr 17;203(4):829-35 [PMID: 16567386]
  93. J Exp Med. 2005 Jul 4;202(1):97-110 [PMID: 15998790]
  94. J Immunol. 1982 Oct;129(4):1627-31 [PMID: 6809826]
  95. J Immunol. 1999 Feb 1;162(3):1278-86 [PMID: 9973380]
  96. Biochimie. 2010 Jun;92(6):692-7 [PMID: 20167241]
  97. J Lipid Res. 2009 Apr;50 Suppl:S237-42 [PMID: 19011112]
  98. J Immunol. 1995 Apr 15;154(8):4123-32 [PMID: 7706749]
  99. J Allergy Clin Immunol. 2009 Jan;123(1):67-73.e3 [PMID: 19062085]
  100. Allergy. 2009 Jul;64(7):995-1002 [PMID: 19630858]
  101. J Exp Med. 1996 Jan 1;183(1):109-17 [PMID: 8551213]
  102. J Biol Chem. 1989 Nov 25;264(33):19469-72 [PMID: 2555321]
  103. Am J Pathol. 2010 May;176(5):2352-66 [PMID: 20304963]
  104. Eur Respir J. 1992 Feb;5(2):190-5 [PMID: 1348480]
  105. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6273-8 [PMID: 9600955]
  106. Ann Rheum Dis. 1995 Nov;54(11):930-3 [PMID: 7492245]
  107. J Exp Med. 2006 Apr 17;203(4):837-42 [PMID: 16567388]
  108. J Biol Chem. 2008 Apr 25;283(17):11097-106 [PMID: 18285344]
  109. Pharmacol Rev. 2006 Sep;58(3):375-88 [PMID: 16968946]
  110. Immunol Today. 1997 Jul;18(7):320-4 [PMID: 9238834]
  111. Curr Top Med Chem. 2006;6(13):1427-44 [PMID: 16918458]
  112. J Exp Med. 2008 Apr 14;205(4):759-66 [PMID: 18378794]
  113. J Exp Med. 2000 Aug 7;192(3):421-32 [PMID: 10934230]
  114. FASEB J. 2010 Feb;24(2):637-47 [PMID: 19843712]
  115. J Exp Med. 2000 Aug 7;192(3):439-46 [PMID: 10934232]
  116. J Clin Invest. 2001 Jun;107(11):1357-64 [PMID: 11390417]
  117. Trends Pharmacol Sci. 2008 Feb;29(2):72-8 [PMID: 18187210]
  118. J Biol Chem. 1999 Mar 5;274(10):6027-30 [PMID: 10037679]
  119. J Immunol. 2009 Jan 1;182(1):623-35 [PMID: 19109196]
  120. Nature. 1997 Jun 5;387(6633):620-4 [PMID: 9177352]
  121. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7158-62 [PMID: 8346230]
  122. Nat Rev Immunol. 2009 Jan;9(1):9-13 [PMID: 19039320]
  123. Science. 2000 Mar 17;287(5460):2013-7 [PMID: 10720327]

Grants

  1. P30 AI060354/NIAID NIH HHS
  2. R01 AI050892/NIAID NIH HHS

MeSH Term

Animals
Arthritis, Experimental
Asthma
Chemokines
Chemotactic Factors
Chemotaxis, Leukocyte
Cytokines
Gene Expression Regulation
Humans
Inflammation
Inflammation Mediators
Leukocytes
Leukotriene B4
Lipids
Mice
Neutrophils
Receptors, G-Protein-Coupled
Receptors, Leukotriene B4
Signal Transduction
Th2 Cells

Chemicals

Chemokines
Chemotactic Factors
Cytokines
Inflammation Mediators
Lipids
Receptors, G-Protein-Coupled
Receptors, Leukotriene B4
Leukotriene B4

Word Cloud

Created with Highcharts 10.0.0recruitmentimmuneleukocytecellschemoattractantsfunctionvivoChemoattractantsmediatorssitesinflammationchemokinescytokinesinducepivotalhostdefenseorchestratinginfectiondisplayvastchemicaldiversityincludebioactivelipidsproteolyticfragmentsserumproteinschemotacticchemotaxisactivatingseven-transmembrane-spanningGPCRsexpressedestablishingconceptrelatedHoweveralthoughoverlappingfunctionsvitrorecentdatarevealedmanycasesnonredundantlychemicallydiversenaturecontributesfinecontroltraffickingsequentialchemoattractantuseguidingcellinflammatoryLipidfrequentlyinitiatorsattractingfirsttissuesinitialrespondingproducelocallyturnlocalreleaseLocalchemokineproductionmarkedlyamplifiessubsequentwavesnewdiscoveriesestablishparadigminflammation--describedlipid-cytokine-chemokinecascades--asdrivingforceeffectorphaseresponsesLipid-cytokine-chemokinecascadesorchestrate

Similar Articles

Cited By